Skip to content

Public FDA record

Z-0491-2021: Geistlich Bio-Oss Pen 0.25-1mm 0.5g - Product Usage: natural bone mineral for filling of bone defects in

Recall record Z-0491-2021 for Geistlich Pharma North America, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0491-2021
Company in FDA record
Geistlich Pharma North America, Inc.
FDA record creation date
Nov 25, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Difficult to expel Geistlich Bio-Oss granules from the pen, resistance could suddenly drop, and the granules may be expelled all at once, causing surrounding tissue, particularly in use for the sinus lift indication and while unlikely, could pose a risk for patient harm, including irritation of the oral mucosa or even a perforation of the Schneiderian membrane

Source facts

Action
Geistlich Pharma North America, Inc. issued Urgent Medical Device Notification letter on 10/19/20 stating reason for recall, health risk and action to take: Action Requested of Customer 1. Please complete the Acknowledgement and Receipt Form even if you do not have affected product on hand. 2. If you still have inventory of Geistlich Bio-Oss Pen with the impacted lot numbers, please immediately discontinue use and return all affected product together with the completed response form. A customer care representative will contact you to coordinate your refund and/or a replacement of goods. 3. If you have experienced this issue and have not reported this to date, please contact Geistlich Pharma North America, Inc. 4. If the product has been further distributed to other customers, please forward this notice and report to Geistlich Pharma North America. We apologize for this inconvenience and appreciate your attention to this matter. If you have any questions, please contact us at 855-799-5500 or orders@geistlich-na.com
Initiated
2020-10-19
Root cause
Device Design
Terminated
2021-07-13
Distribution
Worldwide distribution - US Nationwide distribution and the country of Japan.
Recall number
Z-0491-2021
Recall status
Terminated
CDRH record ID
184213
FDA record created
2020-11-25
Recall event number
86628

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗